Brooksbank M A, Game P A, Ashby M A
Royal Adelaide Hospital, North Terrace, South Australia, Australia.
Palliat Med. 2002 Nov;16(6):520-6. doi: 10.1191/0269216302pm590oa.
This retrospective clinical study reports on the experience of palliative venting gastrostomy (PVG) in an integrated acute teaching hospital and hospice-based palliative care service over a seven-year period (1989-97). PVG was performed for 51 patients with refractory nausea and vomiting resulting from varying degrees and levels of persisting or intermittent malignant bowel obstruction. There were 32 females and 19 males; the mean age was 61 years (range 25-86 years). All patients had advanced and incurable cancer with intra-abdominal spread, originating from the following primary sites: colon and rectum (27), ovary (16), breast (2), pancreas (2), and other (4). The venting gastrostomy tube was inserted endoscopically by a railroading technique in 46 patients (using a 16- to 20-French Dobhoff PEG tube), at open laparotomy in four cases and under radiological (abdominal computerized tomography) control in one case. Endoscopic insertion was attempted and abandoned for technical reasons in a further two cases. The median survival of all 51 patients from the time of gastrostomy insertion was 17 days (range 1-190). In 47/51 (92%), the symptoms of nausea and vomiting were relieved by the procedure, and these patients experienced restoration of some level of oral soft food and fluid intake. Twenty patients were discharged home, and six died at home. In a small group of highly selected patients, for whom pharmacological measures failed to palliate the effects of malignant bowel obstruction, PVG was shown to be a safe and effective means of abolishing or substantially improving vomiting. Provided that the intervention is appropriate to the given clinical situation and acceptable to the patient, it should be considered.
这项回顾性临床研究报告了一家综合性急性教学医院和临终关怀姑息治疗服务机构在七年期间(1989 - 1997年)进行姑息性排气胃造口术(PVG)的经验。对51例因不同程度和持续或间歇性恶性肠梗阻导致难治性恶心和呕吐的患者进行了PVG。其中女性32例,男性19例;平均年龄61岁(范围25 - 86岁)。所有患者均患有晚期不可治愈的癌症且有腹腔内转移,原发部位如下:结肠和直肠(27例)、卵巢(16例)、乳腺(2例)、胰腺(2例)和其他(4例)。46例患者通过铁路技术在内镜下插入排气胃造口管(使用16至20法式的多布霍夫经皮内镜下胃造口管),4例通过开腹手术,1例在放射学(腹部计算机断层扫描)控制下进行。另外2例因技术原因尝试内镜插入但未成功。51例患者自胃造口插入时起的中位生存期为17天(范围1 - 190天)。47/51(92%)的患者恶心和呕吐症状通过该手术得到缓解,这些患者恢复了一定程度的口服软食和液体摄入。20例患者出院回家,6例在家中死亡。对于一小部分经过严格挑选、药物治疗未能缓解恶性肠梗阻影响的患者,PVG被证明是一种消除或显著改善呕吐的安全有效方法。只要该干预措施适合特定的临床情况且患者能够接受,就应予以考虑。